In analyzed clinical studies, IFN-gamma was elevated in patients staged I-III and I-IV in relation to controls, and in stage IV patients compared to less advanced stages (I, II, III), confirming the importance of this cytokine in CRC development (Table 1 and Table 2). Here, IFNG is linked to colorectal carcinoma.